Intranasal administration of ketamine to treat depression

Details for Australian Patent Application No. 2007229866 (hide)

Owner Mount Sinai School of Medicine Yale University School of Medicine The Gov. of the USA, as represented by The Secretary of Health & Human Services National Institutes

Inventors Mathew, Sanjay J.; Charney, Dennis S.; Zarate Jr., Carlos A.; Krystal, John H.; Manji, Husseini K.

Agent Spruson & Ferguson

Pub. Number AU-A-2007229866

PCT Pub. Number WO2007/111880

Priority 60/785,108 22.03.06 US

Filing date 20 March 2007

Wipo publication date 4 October 2007

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

Event Publications

13 November 2008 PCT application entered the National Phase

  PCT publication WO2007/111880 Priority application(s): WO2007/111880

18 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007229870-Beverage forming device with opening/ closing mechanism for beverage cartridge receiver

2007229854-Method and apparatus for converting direct current to alternating current